House Panel Turns Up Heat On J&J Over Recalls

Law360, New York (June 3, 2010, 3:28 PM EDT) -- Congressional scrutiny on Johnson & Johnson Services Inc. is increasing, with a U.S. House of Representatives committee launching probes into whether the company conducted “phantom” recalls of Motrin in 2008 and its connection to a recently announced recall of PediaCare made at a J&J plant.

The House Committee on Oversight and Government Reform on Wednesday pressed the pharmaceutical giant's CEO, William C. Weldon, for details on a 2008 “phantom” recall of certain types of Motrin, which the committee first uncovered while reviewing documents turned over by...
To view the full article, register now.